Trehalose reduces retinal degeneration, neuroinflammation and storage burden caused by a lysosomal hydrolase deficiency

References

• Lorincz AE. The mucopolysaccharidoses: advances in understanding and treatment. Pediatr Ann. 1978 Feb;7(2):104–122. PubMed PMID: 415287.
   PubMed Web of Science ®Google Scholar
• Heron B, Mikaeloff Y, Froissart R, et al. Incidence and natural history of mucopolysaccharidosis type III in France and comparison with United Kingdom and Greece. Am J Med Genet Part A. 2011 Jan;155a(1):58–68. PubMed PMID: 21204211.
   PubMed Web of Science ®Google Scholar
• Mumford RA, Mahon LV, Jones S, et al. Actigraphic investigation of circadian rhythm functioning and activity levels in children with mucopolysaccharidosis type III (Sanfilippo syndrome). J Neurodev Disord. 2015;7(1):31. PubMed PMID: 26388955; PubMed Central PMCID: PMCPMC4574189.
   PubMed Web of Science ®Google Scholar
• Meyer A, Kossow K, Gal A, et al. Scoring evaluation of the natural course of mucopolysaccharidosis type IIIA (Sanfilippo syndrome type A). Pediatrics. 2007 Nov;120(5):e1255–61. PubMed PMID: 17938166.
   PubMed Web of Science ®Google Scholar
• Ashworth JL, Biswas S, Wraith E, et al. Mucopolysaccharidoses and the eye. Surv Ophthalmol. 2006 Jan–Feb;51(1):1–17. PubMed PMID: 16414358.
   PubMed Web of Science ®Google Scholar
• Husain AM, Escolar ML, Kurtzberg J. Neurophysiologic assessment of mucopolysaccharidosis III. Clin Neurophysiol. 2006 Sep;117(9):2059–2063. PubMed PMID: 16884953.
   PubMed Web of Science ®Google Scholar
• Tamagawa K, Morimatsu Y, Fujisawa K, et al. Neuropathological study and chemico-pathological correlation in sibling cases of Sanfilippo syndrome type B. Brain Dev. 1985;7(6):599–609. PubMed PMID: 3938624.
   PubMed Web of Science ®Google Scholar
• Rafi MA, Zhi Rao H, Passini MA, et al. AAV-mediated expression of galactocerebrosidase in brain results in attenuated symptoms and extended life span in murine models of globoid cell leukodystrophy. Mol Ther. 2005 May;11(5):734–744. PubMed PMID: 15851012.
   PubMed Web of Science ®Google Scholar
• Fraldi A, Hemsley K, Crawley A, et al. Functional correction of CNS lesions in an MPS-IIIA mouse model by intracerebral AAV-mediated delivery of sulfamidase and SUMF1 genes. Hum Mol Genet. 2007 Nov 15;16(22):2693–2702. PubMed PMID: 17725987.
   PubMed Web of Science ®Google Scholar
• Cearley CN, Wolfe JH. A single injection of an adeno-associated virus vector into nuclei with divergent connections results in widespread vector distribution in the brain and global correction of a neurogenetic disease. J Neurosci. 2007 Sep 12;27(37):9928–9940. PubMed PMID: 17855607. .
   PubMed Web of Science ®Google Scholar
• Passini MA, Bu J, Fidler JA, et al. Combination brain and systemic injections of AAV provide maximal functional and survival benefits in the Niemann-Pick mouse. Proc Natl Acad Sci U S A. 2007 May 29;104(22):9505–9510. PubMed PMID: 17517638; PubMed Central PMCID: PMCPMC1874225.
   PubMed Web of Science ®Google Scholar
• Gilkes JA, Heldermon CD. Mucopolysaccharidosis III (Sanfilippo Syndrome)- disease presentation and experimental therapies. Pediatr Endocrinol Rev. 2014 Sep;12(Suppl 1):133–140. PubMed PMID: 25345095.
   PubMed Web of Science ®Google Scholar
• Kan SH, Aoyagi-Scharber M, Le SQ, et al. Delivery of an enzyme-IGFII fusion protein to the mouse brain is therapeutic for mucopolysaccharidosis type IIIB. Proc Natl Acad Sci U S A. 2014 Oct 14;111(41):14870–14875. PubMed PMID: 25267636; PubMed Central PMCID: PMCPmc4205671.
   PubMed Web of Science ®Google Scholar
• Hemsley KM, Hopwood JJ. Delivery of recombinant proteins via the cerebrospinal fluid as a therapy option for neurodegenerative lysosomal storage diseases. Int J Clin Pharmacol Ther. 2009;47(Suppl 1):S118–23. PubMed PMID: 20040322.
   PubMed Web of Science ®Google Scholar
• Prasad VK, Kurtzberg J. Emerging trends in transplantation of inherited metabolic diseases. Bone Marrow Transplant. 2008 Jan;41(2):99–108. PubMed PMID: 18176609.
   PubMed Web of Science ®Google Scholar
• Di Domenico C, Villani GR, Di Napoli D, et al. Intracranial gene delivery of LV-NAGLU vector corrects neuropathology in murine MPS IIIB. Am J Med Genet Part A. 2009 Jun;149a(6):1209–1218. PubMed PMID: 19449420.
   PubMed Web of Science ®Google Scholar
• Sardiello M, Palmieri M, di Ronza A, et al. A gene network regulating lysosomal biogenesis and function. Science (New York, NY). 2009 Jul 24;325(5939):473–477. PubMed PMID: 19556463.
   Google Scholar
• Settembre C, Di Malta C, Polito VA, et al. TFEB links autophagy to lysosomal biogenesis. Science (New York, NY). 2011 Jun 17;332(6036):1429–1433. PubMed PMID: 21617040; PubMed Central PMCID: PMCPmc3638014.
   Google Scholar
• Medina DL, Fraldi A, Bouche V, et al. Transcriptional activation of lysosomal exocytosis promotes cellular clearance. Dev Cell. 2011 Sep 13;21(3):421–430. PubMed PMID: 21889421; PubMed Central PMCID: PMCPmc3173716.
   PubMed Web of Science ®Google Scholar
• Song W, Wang F, Savini M, et al. TFEB regulates lysosomal proteostasis. Hum Mol Genet. 2013 May 15;22(10):1994–2009. PubMed PMID: 23393155.
   PubMed Web of Science ®Google Scholar
• Tsunemi T, Ashe TD, Morrison BE, et al. PGC-1alpha rescues Huntington’s disease proteotoxicity by preventing oxidative stress and promoting TFEB function. Sci Transl Med. 2012 Jul 11;4(142):142ra97. PubMed PMID: 22786682; PubMed Central PMCID: PMCPmc4096245.
   PubMed Web of Science ®Google Scholar
• Decressac M, Mattsson B, Weikop P, et al. TFEB-mediated autophagy rescues midbrain dopamine neurons from alpha-synuclein toxicity. Proc Natl Acad Sci U S A. 2013 May 7;110(19):E1817–26. PubMed PMID: 23610405; PubMed Central PMCID: PMCPmc3651458.
   PubMed Web of Science ®Google Scholar
• Decressac M, Björklund A. TFEB: pathogenic role and therapeutic target in Parkinson disease. Autophagy. 2013 Aug;9(8):1244–1246. PubMed PMID: 23715007; PubMed Central PMCID: PMCPmc3748195.
   PubMed Web of Science ®Google Scholar
• Xiao Q, Yan P, Ma X, et al. Neuronal-targeted TFEB accelerates lysosomal degradation of APP, reducing abeta generation and amyloid plaque pathogenesis. J Neurosci. 2015 Sep 2;35(35):12137–12151. PubMed PMID: 26338325; PubMed Central PMCID: PMCPmc4556784.
   PubMed Web of Science ®Google Scholar
• Polito VA, Li H, Martini-Stoica H, et al. Selective clearance of aberrant tau proteins and rescue of neurotoxicity by transcription factor EB. EMBO Mol Med. 2014 Sep;6(9):1142–1160. PubMed PMID: 25069841; PubMed Central PMCID: PMCPmc4197862.
   PubMed Web of Science ®Google Scholar
• Bouche V, Espinosa AP, Leone L, et al. Drosophila Mitf regulates the V-ATPase and the lysosomal-autophagic pathway. Autophagy. 2016 Mar 3;12(3):484–498. PubMed PMID: 26761346; PubMed Central PMCID: PMCPMC4835958.
   PubMed Web of Science ®Google Scholar
• Sardiello M. Transcription factor EB: from master coordinator of lysosomal pathways to candidate therapeutic target in degenerative storage diseases. Ann N Y Acad Sci. 2016 May;1371(1):3–14. PubMed PMID: 27299292.
   PubMed Web of Science ®Google Scholar
• Lieberman AP, Puertollano R, Raben N, et al. Autophagy in lysosomal storage disorders. Autophagy. 2012 May 1;8(5):719–730. PubMed PMID: 22647656; PubMed Central PMCID: PMCPMC3378416.
   PubMed Web of Science ®Google Scholar
• Settembre C, Fraldi A, Rubinsztein DC, et al. Lysosomal storage diseases as disorders of autophagy. Autophagy. 2008 Jan;4(1):113–114. PubMed PMID: 18000397.
   PubMed Web of Science ®Google Scholar
• Castillo K, Nassif M, Valenzuela V, et al. Trehalose delays the progression of amyotrophic lateral sclerosis by enhancing autophagy in motoneurons. Autophagy. 2013 Sep;9(9):1308–1320. PubMed PMID: 23851366.
   PubMed Web of Science ®Google Scholar
• Ejlerskov P, Rasmussen I, Nielsen TT, et al. Tubulin polymerization-promoting protein (TPPP/p25alpha) promotes unconventional secretion of alpha-synuclein through exophagy by impairing autophagosome-lysosome fusion. J Biol Chem. 2013 Jun 14;288(24):17313–17335. PubMed PMID: 23629650; PubMed Central PMCID: PMCPmc3682534.
   PubMed Web of Science ®Google Scholar
• Ghavami S, Shojaei S, Yeganeh B, et al. Autophagy and apoptosis dysfunction in neurodegenerative disorders. Prog Neurobiol. 2014 Jan;112:24–49. PubMed PMID: 24211851.
   PubMed Web of Science ®Google Scholar
• Gomes C, Escrevente C, Costa J. Mutant superoxide dismutase 1 overexpression in NSC-34 cells: effect of trehalose on aggregation, TDP-43 localization and levels of co-expressed glycoproteins. Neurosci Lett. 2010 May 21;475(3):145–149. PubMed PMID: 20363292. .
   PubMed Web of Science ®Google Scholar
• Li Y, Guo Y, Wang X, et al. Trehalose decreases mutant SOD1 expression and alleviates motor deficiency in early but not end-stage amyotrophic lateral sclerosis in a SOD1-G93A mouse model. Neuroscience. 2015 Jul 9;298:12–25. PubMed PMID: 25841320.
   PubMed Web of Science ®Google Scholar
• Lin F, Qin ZH. Degradation of misfolded proteins by autophagy: is it a strategy for Huntington’s disease treatment? J Huntington’s Dis. 2013;2(2):149–157. PubMed PMID: 25063512.
   PubMedGoogle Scholar
• Sarkar S, Rubinsztein DC. Huntington’s disease: degradation of mutant huntingtin by autophagy. FEBS J. 2008 Sep;275(17):4263–4270. PubMed PMID: 18637946.
   PubMed Web of Science ®Google Scholar
• Zhang X, Chen S, Song L, et al. MTOR-independent, autophagic enhancer trehalose prolongs motor neuron survival and ameliorates the autophagic flux defect in a mouse model of amyotrophic lateral sclerosis. Autophagy. 2014 Apr;10(4):588–602. PubMed PMID: 24441414; PubMed Central PMCID: PMCPmc4091147.
   PubMed Web of Science ®Google Scholar
• Beranger F, Crozet C, Goldsborough A, et al. Trehalose impairs aggregation of PrPSc molecules and protects prion-infected cells against oxidative damage. Biochem Biophys Res Commun. 2008 Sep 12;374(1):44–48. PubMed PMID: 18602368.
   PubMed Web of Science ®Google Scholar
• Aguib Y, Heiseke A, Gilch S, et al. Autophagy induction by trehalose counteracts cellular prion infection. Autophagy. 2009 Apr;5(3):361–369. PubMed PMID: 19182537.
   PubMed Web of Science ®Google Scholar
• Schaeffer V, Goedert M. Stimulation of autophagy is neuroprotective in a mouse model of human tauopathy. Autophagy. 2012 Nov;8(11):1686–1687. PubMed PMID: 22874558; PubMed Central PMCID: PMCPMC3494601.
   PubMed Web of Science ®Google Scholar
• Tanaka M, Machida Y, Niu S, et al. Trehalose alleviates polyglutamine-mediated pathology in a mouse model of Huntington disease. Nat Med. 2004 Feb;10(2):148–154. PubMed PMID: 14730359.
   PubMed Web of Science ®Google Scholar
• Sarkar S, Chigurupati S, Raymick J, et al. Neuroprotective effect of the chemical chaperone, trehalose in a chronic MPTP-induced Parkinson’s disease mouse model. Neurotoxicology. 2014 Sep;44:250–262. PubMed PMID: 25064079.
   PubMed Web of Science ®Google Scholar
• Heldermon CD, Hennig AK, Ohlemiller KK, et al. Development of sensory, motor and behavioral deficits in the murine model of Sanfilippo syndrome type B. PLoS One. 2007;2(8):e772. PubMed PMID: 17712420; PubMed Central PMCID: PMCPmc1945015.
   PubMed Web of Science ®Google Scholar
• Tse DY, Lotfi P, Simons DL, et al. Electrophysiological and histological characterization of rod-cone retinal degeneration and microglia activation in a mouse model of mucopolysaccharidosis type IIIB. Sci Rep. 2015;5:17143. PubMed PMID: 26607664; PubMed Central PMCID: PMCPmc4660851.
   PubMed Web of Science ®Google Scholar
• Cideciyan AV, Jacobson SG. An alternative phototransduction model for human rod and cone ERG a-waves: normal parameters and variation with age. Vision Res. 1996 Aug;36(16):2609–2621. PubMed PMID: 8917821.
   PubMed Web of Science ®Google Scholar
• Simons DL, Boye SL, Hauswirth WW, et al. Gene therapy prevents photoreceptor death and preserves retinal function in a Bardet-Biedl syndrome mouse model. Proc Natl Acad Sci U S A. 2011 Apr 12;108(15):6276–6281. PubMed PMID: 21444805; PubMed Central PMCID: PMC3076852.
   PubMed Web of Science ®Google Scholar
• Caruso RC, Kaiser-Kupfer MI, Muenzer J, et al. Electroretinographic findings in the mucopolysaccharidoses. Ophthalmology. 1986 Dec;93(12):1612–1616. PubMed PMID: 3101020.
   PubMed Web of Science ®Google Scholar
• Ohmi K, Greenberg DS, Rajavel KS, et al. Activated microglia in cortex of mouse models of mucopolysaccharidoses I and IIIB. Proc Natl Acad Sci U S A. 2003 Feb 18;100(4):1902–1907. PubMed PMID: 12576554; PubMed Central PMCID: PMCPmc149931.
   PubMed Web of Science ®Google Scholar
• Palmieri M, Impey S, Kang H, et al. Characterization of the CLEAR network reveals an integrated control of cellular clearance pathways. Hum Mol Genet. 2011 Oct 1;20(19):3852–3866. PubMed PMID: 21752829.
   PubMed Web of Science ®Google Scholar
• Ohmi K, Zhao H-Z, Neufeld EF. Defects in the medial entorhinal cortex and dentate gyrus in the mouse model of Sanfilippo syndrome type B. PLoS One. 2011;6(11):e27461. PubMed PMID: 22096577; PubMed Central PMCID: PMCPMC3212581.
   PubMed Web of Science ®Google Scholar
• Peña-Llopis S, Vega-Rubin-de-Celis S, Schwartz JC, et al. Regulation of TFEB and V-ATPases by mTORC1. EMBO J. 2011 Jul 29;30(16):3242–3258. PubMed PMID: 21804531; PubMed Central PMCID: PMCPMC3160667.
   PubMed Web of Science ®Google Scholar
• Malinowska M, Wilkinson FL, Bennett W, et al. Genistein reduces lysosomal storage in peripheral tissues of mucopolysaccharide IIIB mice. Mol Genet Metab. 2009 Nov;98(3):235–242. PubMed PMID: 19632871.
   PubMed Web of Science ®Google Scholar
• Xie Y, Zhou B, Lin M-Y, et al. Progressive endolysosomal deficits impair autophagic clearance beginning at early asymptomatic stages in fALS mice. Autophagy. 2015 Oct 3;11(10):1934–1936. PubMed PMID: 26290961.
   PubMed Web of Science ®Google Scholar
• Gontier G, George C, Chaker Z, et al. Blocking IGF signaling in adult neurons alleviates Alzheimer’s disease pathology through amyloid-beta clearance. J Neurosci. 2015 Aug 19;35(33):11500–11513. PubMed PMID: 26290229.
   PubMed Web of Science ®Google Scholar
• Komatsu M, Waguri S, Chiba T, et al. Loss of autophagy in the central nervous system causes neurodegeneration in mice. Nature. 2006 Jun 15;441(7095):880–884. PubMed PMID: 16625205.
   PubMed Web of Science ®Google Scholar
• Rubinsztein DC, DiFiglia M, Heintz N, et al. Autophagy and its possible roles in nervous system diseases, damage and repair. Autophagy. 2005 Apr;1(1):11–22. PubMed PMID: 16874045.
   PubMed Web of Science ®Google Scholar
• Ahmed I, Liang Y, Schools S, et al. Development and characterization of a new Parkinson’s disease model resulting from impaired autophagy. J Neurosci. 2012 Nov 14;32(46):16503–16509. PubMed PMID: 23152632; PubMed Central PMCID: PMCPmc3508432.
   PubMed Web of Science ®Google Scholar
• Seki T, Abe-Seki N, Kikawada T, et al. Effect of trehalose on the properties of mutant {gamma}PKC, which causes spinocerebellar ataxia type 14, in neuronal cell lines and cultured Purkinje cells. J Biol Chem. 2010 Oct 22;285(43):33252–33264. PubMed PMID: 20705605; PubMed Central PMCID: PMCPmc2963337.
   PubMed Web of Science ®Google Scholar
• Schneider JL, Cuervo AM. Chaperone-mediated autophagy: dedicated saviour and unfortunate victim in the neurodegeneration arena. Biochem Soc Trans. 2013 Dec;41(6):1483–1488. PubMed PMID: 24256241; PubMed Central PMCID: PMCPmc4000258.
   PubMed Web of Science ®Google Scholar
• Cuervo AM, Wong ES, Martinez-Vicente M. Protein degradation, aggregation, and misfolding. Move Disord. 2010;25 Suppl 1:S49–54. PubMed PMID: 20187257.
   PubMed Web of Science ®Google Scholar
• Fernandez-Estevez MA, Casarejos MJ, Lopez Sendon J, et al. Trehalose reverses cell malfunction in fibroblasts from normal and Huntington’s disease patients caused by proteosome inhibition. PLoS One. 2014;9(2):e90202. PubMed PMID: 24587280; PubMed Central PMCID: PMCPmc3934989.
   PubMed Web of Science ®Google Scholar
• Mayer AL, Higgins CB, Heitmeier MR, et al. SLC2A8 (GLUT8) is a mammalian trehalose transporter required for trehalose-induced autophagy. Sci Rep. 2016 Dec 6;6:38586.
   PubMed Web of Science ®Google Scholar
• DeBosch BJ, Heitmeier MR, Mayer AL, et al. Trehalose inhibits solute carrier 2A (SLC2A) proteins to induce autophagy and prevent hepatic steatosis. Sci Signal. 2016 Feb 23;9(416):ra21. PubMed PMID: 26905426; PubMed Central PMCID: PMCPMC4816640. .
   PubMed Web of Science ®Google Scholar
• Palmieri M, Pal R, Nelvagal HR, et al. mTORC1-independent TFEB activation via Akt inhibition promotes cellular clearance in neurodegenerative storage diseases. Nat Commun. 2017 Feb 6;8:14338.
   PubMed Web of Science ®Google Scholar
• Xiao Q, Yan P, Ma X, et al. Enhancing astrocytic lysosome biogenesis facilitates Abeta clearance and attenuates amyloid plaque pathogenesis. J Neurosci. 2014 Jul 16;34(29):9607–9620. PubMed PMID: 25031402; PubMed Central PMCID: PMCPmc4099542. .
   PubMed Web of Science ®Google Scholar
• Richards AB, Krakowka S, Dexter LB, et al. Trehalose: a review of properties, history of use and human tolerance, and results of multiple safety studies. Food Chem Toxicol. 2002 Jul;40(7):871–898. PubMed PMID: 12065209.
   PubMed Web of Science ®Google Scholar
• Ribera A, Haurigot V, Garcia M, et al. Biochemical, histological and functional correction of mucopolysaccharidosis type IIIB by intra-cerebrospinal fluid gene therapy. Hum Mol Genet. 2015 Apr 1;24(7):2078–2095. PubMed PMID: 25524704.
   PubMed Web of Science ®Google Scholar
• Delgadillo V, O’Callaghan Mdel M, Gort L, et al. Natural history of Sanfilippo syndrome in Spain. Orphanet J Rare Dis. 2013;8:189. PubMed PMID: 24314109; PubMed Central PMCID: PMCPmc3879199.
   PubMed Web of Science ®Google Scholar
• Katz ML, Tecedor L, Chen Y, et al. AAV gene transfer delays disease onset in a TPP1-deficient canine model of the late infantile form of Batten disease. Sci Transl Med. 2015 Nov 11;7(313):313ra180. PubMed PMID: 26560358.
   PubMed Web of Science ®Google Scholar
• Sorrentino NC, D’Orsi L, Sambri I, et al. A highly secreted sulphamidase engineered to cross the blood-brain barrier corrects brain lesions of mice with mucopolysaccharidoses type IIIA. EMBO Mol Med. 2013 May;5(5):675–690. PubMed PMID: 23568409; PubMed Central PMCID: PMCPmc3662312.
   PubMed Web of Science ®Google Scholar
• Mirza M, Volz C, Karlstetter M, et al. Progressive retinal degeneration and glial activation in the CLN6 (nclf) mouse model of neuronal ceroid lipofuscinosis: a beneficial effect of DHA and curcumin supplementation. PloS One. 2013;8(10):e75963. PubMed PMID: 24124525; PubMed Central PMCID: PMCPmc3790850.
   PubMed Web of Science ®Google Scholar
• Food and Agriculture Organization/World Health Organization Expert Committee on Food Additives. Evaluation of certain food additives and contaminants. World Health Organ Tech Rep Ser. 2001;901:i-viii, x, 1–107. PubMed PMID: 11588830.
   PubMedGoogle Scholar
• Traynor BJ, Bruijn L, Conwit R, et al. Neuroprotective agents for clinical trials in ALS: a systematic assessment. Neurology. 2006 Jul 11;67(1):20–27. PubMed PMID: 16832072.
   PubMed Web of Science ®Google Scholar
• Prut L, Belzung C. The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review. Eur J Pharmacol. 2003 Feb 28;463(1–3):3–33. PubMed PMID: 12600700.
   PubMed Web of Science ®Google Scholar
• Saszik SM, Robson JG, Frishman LJ. The scotopic threshold response of the dark-adapted electroretinogram of the mouse. J Physiol. 2002 Sep 15;543(Pt 3):899–916. PubMed PMID: 12231647; PubMed Central PMCID: PMC2290546.
   PubMed Web of Science ®Google Scholar
• Abd-El-Barr MM, Pennesi ME, Saszik SM, et al. Genetic dissection of rod and cone pathways in the dark-adapted mouse retina. J Neurophysiol. 2009 Sep;102(3):1945–1955. PubMed PMID: 19587322; PubMed Central PMCID: PMC2746771.
   PubMed Web of Science ®Google Scholar